To access the protective efficacy of the serum, various amounts of pooled serum from the immunized mice were passively transferred i.p. to naïve IFN-α/βR−/− mice 24 hours prior to i.n. infection with MuV-IA. This evidence concerns the gene IFNA1 and infection.